May/June Newsmakers

Berchuck-Named Gynecologic Oncology Endowed Lectureship Launches
Features Andrew Berchuck, MD

LeBlanc Honored for Advocacy, Named Education Chair for ASCO24
Features Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Akinyemiju, Garman, and Zani Receive Faculty Awards
Features Tomi Akinyemiju, PhD; Katherine Garman, MD, MHS; Sabino Zani Jr., MD

Ten DCI Faculty Awarded Distinguished Professorships
Features Peter Allen, MD, PhD; Michel Bagnat, PhD; Daniel George, MD; Gerald Grant, MD; Matthias Gromeier, MD; Susan Halabi, PhD; Seok-Yong Lee, PhD; Steven Patierno, PhD; John Rawls, PhD; Beth Sullivan, PhD

Three DCI Nurses Win FON Excellence Awards
Features Deborah “Hutch” Allen, PhD, RN, CNS, FNP-BC, AOCNP; Nicole “Nicki” Murray Coates, BSN, RN, OCN; and Meagan Salmon, BSN, RN, OCN

Annual Men's Health Screening Draws a Crowd
Features Angelo Moore, PhD, RN, NE-BC, and Kearston Ingraham, MHA

AI-Driven Biomarker Predicts Optimum Length of Treatment for Prostate Cancer
Features Andrew Armstrong, MD, MSc

Black Men with Metastatic Prostate Cancer May Benefit From Drug Combination 
Features Daniel George, MD
Plus: Dan George ASCO Twitter video explaining his research

Oncologist & Patient Talk About Their 16-Year Multiple Myeloma Journey in Video Podcast 
Features Cristina Gasparetto, MD, and her patient Thomas Goode

Allen Named DUHS Vice President for Cancer Services
Features Peter Allen, MD, PhD

Cancer Takes its Toll on St. Pauls Woman, but Can’t Steal Her Joy for Life
Features Hannah McManus, MD

ICYMI at DUKE

Creating Community for Asian American Students (Duke School of Medicine)
Features Duke Cancer Center

Lafata Recognized with Professorship Named for Duke RadOnc Legend (Duke RadOnc)
Features Kyle J. Lafata, PhD

Medical Students Select 2023 Golden Apple Award (Duke School of Medicine)
Features Kristen Rhodin, MD

New Focus on Improving Melanoma Therapies for Older Patients (Clinical Practice Today)
Features Jay Lee, MD, in Wake County

Head and Neck Cancer Awareness month screening at Mudcats game (Department of Head & Neck Surgery and Communication Sciences
Features Trinitia Cannon, MD

This is Something We Haven't Seen in 20 Years" New Brain Tumor Treatment May Extend Life and Slow Difficult Treatment Options (Duke Neurology)
Features Katy Peters, MD, PhD

Alexandra Bennion Receives Biology Faculty Award (Duke Pathology)

More Options for People with Blood Cancers (Duke SoM Magnify)
Features Mitchell Horwitz, MD

Forward Together: Building a Culture of Encouragement: By supporting a colleague’s growth, Duke Blood Cancer Center creates a spirit of togetherness (Duke Today)
Features Mary Beth Christen, BSN, RN, BMTCN

Michelle Winn Awards Celebrate Achievements in Diversity and Inclusion (Duke School of Medicine) 
Features Tomi Akinyemiju, PhD

Duke Scientists Uncover Ferroptosis as a Potential “Achilles Heel” in RB1-Deficient Prostate Cancer (Duke Pathology)
Featuring Ming Chen, PhD, and fellow Mu-En Wang, PhD, Jiaoti Huang, MD, PhD, and Andrew Armstrong, MD, MSc

Individualized Care, Experienced Specialists Lead GI Cancer Team in Wake (Clinical Practice Today)
Features Garth Herbert, MD

House Cancer Caucus Briefing on Chemotherapy Shortages (Duke Ob/Gyn Blog)
Features Angeles Alvarez Secord, MD, MHSc

Kidney Donor Evaluation Leads to Stomach Cancer Discovery (Duke Health)
Features Hope Uronis, MD

Lung Cancer Screening Team Focuses on Reducing Mortality (Clinical Practice Today)
Features Betty Tong, MD

Duke U Commencement (Duke University)

WATCH: MD graduates’ Commencement (Duke SoM)

Study Reveals How UV Radiation May Drive Melanoma (Duke School of Medicine)
Features Raluca Gordân, PhD

$5M project brings optimized radiation treatment to Wilson (The Wilson Times)
Features Linda Sutton, MD

Destination Midtown: Duke Raleigh Hospital’s Art Suite (CBS 17)

World-class cancer treatment is now close to home (Murray Ledger & Times)
Features Alexander Diaz, MD, PhD

Encourage men to get screened, health experts say (Butner-Creedmoor News)
Features Duke Cancer Institute

Triangle Cancer patients worry about Chemo shortages (CBS 17)
Features Angeles Alvarez Secord, MD, MHSc

Amidst Advancements in Treating Cancer, Oncologists Face New Challenge: Drug Shortages (ABC-11)
Features Angeles Alvarez Secord, MD, MHSc, and Kristy Sartin

As cancer drug shortages grow, some doctors are forced to ration doses or delay care (NBC News)
Features Angeles Alvarez Secord, MD, MHSc

US cancer drug shortage forces doctors to ration life-saving treatments (The Financial Times)
Features Angeles Alvarez Secord, MD, MHSc

North Carolina cancer patients worry about Chemo drug shortages (WGHP Greensboro)
Features Angeles Alvarez Secord, MD, MHSc

Duke Cancer Center Hosts Annual Survivorship Day (CBS-17)
Features Kristy Sartin and patient Connie High

'It's very important': Duke Cancer Center in Durham offers free health screenings (ABC-11)
Features Angelo Moore, PhD, RN, and patient Bradley Long

NC breast cancer survivor reveals the moment her world changed at 28 (WRAL)
Features Maggie DiNome, MD

'Rocked my world.' Breast cancer survivor reacts to new screening recommendations (ABC-11)
Features Maggie DiNome, MD

'Always about hope': Ukrainian artist with cancer paints new life in North Carolina (ABC-11)
Features Duke Cancer

Pushing a More Complete Picture (Triangle Business Journal)
Features Karen Johnson, MD, MS

The current incidence, evaluation, and management of male breast cancer (SurgOnc Today)
Features Jennifer Plichta, MD, MS

Potential targets against natural killer/T-cell lymphoma found (Labiotech (Eu))
Features Ong Choon Kiat, PhD (Duke NUS)

Study reveals racial inequities in lung cancer screening among veterans (HCP Live)
Features Neelima Navuluri, MD, MPH

Black patients face 34% lower odds of completing lung cancer screening after a referral, (Radiology Business)
Features Neelima Navuluri, MD, MPH

Fewer black veterans complete referrals for lung cancer screening (HealthDay)
Features Neelima Navuluri, MD, MPH

Better With Aging: Improving breast cancer care in older adults (Medscape Video Series)
Features Rebecca Shelby, PhD
Episode 1: The Difference Age Makes
Features Gretchen Kimmick, MD, Rebecca Shelby, PhD, Lisa Massa, MPT

Dr Armstrong on the FDA Approval of Abiraterone/Olaparib Combination in BRCA-mutated mCRPC (OncLive)
Features Andrew Armstrong, MD, MSc

FDA approval insights: Olaparib plus Abiraterone in BRCA-mutated mCRPC (Onc Live) Features Andrew Armstrong, MD, MSc

ODAC decision for Olaparib/ Abiraterone in mCRPC likely to impact forthcoming studies (Targeted Oncology)
Features Andrew Armstrong, MD, MSc

FDA Approves Olaparib Triplet for mCRPC (Targeted Oncology)
Features Andrew Armstrong, MD, MSc

Approval of Olaparib Combo Impacts SOC in BRCA-Mutant Metastatic CRPC (Cancer Network)
Features Andrew Armstrong, MD, MSc

FDA Approves Olaparib Combo in BRCA-Mutated mCRPC (Cancer Network)
Features Andrew Armstrong, MD, MSc

FDA Approves Olaparib Combination to Treat BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer (AJMC)
Features Andrew Armstrong, MD, MSc

FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer (Medpage Today)
Features Andrew Armstrong, MD, MSc

Olaparib Gains BRCA-Mutated Prostate Cancer Indication (Medscape)
Features Andrew Armstrong, MD, MSc

The Evolution of Treatment Paradigms in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (OncLive)
Features Andrew Armstrong, MD, MSc

VIDEO: ASCO® 2023 Insights: "BC Staging for Patients With 'Low-Risk' Disease - Are They All the Same?" (ASCO)
Features Jennifer Plichta, MD, MS

GU’s Shahla Bari MD, speaks in a video at ASCO about the microbiome and immunotherapy treatments for kidney cancer (Twitter)

Gastrointestinal Stromal Tumors That Lack KIT and PDGFRA Mutations (Expert Perspectives in Oncology)
Features Richard Riedel, MD

It's Okay to Say 'No': Setting Boundaries in Oncology (Medscape)
Features Arif Kamal, MD, MBA, MHS

Cancer drug shortages spur worry, rationing and tough choices (MD Edge)
Features Arif Kamal, MD, MBA, MHS

Patients with poor-prognosis metastatic NSCLC benefit from Nivolumab and Ipilimumab (Targeted Oncology)
Features Neal Ready, MD, PhD

ASC officer provides ASCO highlights: Targeting hidden cancer, AI in oncology (MD Edge) Features Arif Kamal, MD, MBA, MHS

Making the Art of Oncology and Cancer Care Central to Her Presidential Term: A Conversation With Lynn M. Schuchter, MD, FASCO (The ASCO Post)
Features Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Investigators of the phase 1/2 KOMET-001 trial are seeking to address unmet needs in AML with the investigational menin inhibitor ziftomenib (OncLive)
Features Harry Erba, MD, PhD

Ziftomenib displays early-phase efficacy in relapsed or refractory AML (Onc Live)
Features Harry Erba, MD, PhD

Taking cardiotoxicity to heart in cancer patients (Pharmacy Practice News)
Features Kristen Peterson, PharmD

Cardiac event management is a key aspect of safely treating patients with Ribociclib in advanced breast cancer (Oncology Nursing News)
Features Rita Deimler, NP

FDA panel rejects broad Olaparib indication in metastatic CRPC (Medpage Today)
Features Daniel George, MD

Onco-nursing experts define best practices, treatment considerations for managing patients with MPNs (Oncology Nursing News)
Features Jill Brennan-Cook, DNP, RN, BC-GERO

Study identifies disparities in prostate cancer screening for transgender women (Urology Times)
Features Hayley Premo, MS (3^rd year med student)

That lump on your testicle doesn’t automatically scream cancer (Get Me Giddy)
Features Aaron Lentz, MD 

Episode 257: Redefining the Bell: The Ethics of Hope for Oncology Nurses and Patients (Oncology Nursing Society)
Features Monica Cfarku, RN, MSN, BMTCN, CCM, NE-BC

Addition of Quizartinib to chemotherapy in newly diagnosed FLT3-ITD-positive acute myeloid leukemia (The ASCO Post)
Features Harry Erba, MD, PhD

Quizartinib Plus Chemotherapy Emerges as Potential Option for FLT3-ITD-Mutant AML (Targeted Oncology)
Features Harry Erba, MD, PhD

FLT3 Inhibitor Doubles Overall Survival in Acute Myeloid Leukemia (Medpage Today)
Features Harry Erba, MD, PhD

Exploring racial biases in clinical trials: The PANTHER study’s findings on prostate cancer, (Uro Today)
Features Daniel George, MD

Emotional Impacts of Side Effects on Patients and Caregivers (Checkpoint Now Podcast Series)
Featuring Afreen Shariff, MD; Tian Zhang, MD; and Rebecca Shelby, PhD

Olatec Therapeutics Announces the Completion of First Dose Cohort in an Innovative Trial Investigating Olatec’s NLRP3 Inhibitor Dapansutrile and Merck’s Keytruda^® in Patients with Advanced Refractory Melanoma at Duke Cancer Institute (Olatec Therapeutics press release)
Features April Salama, MD

(BOOK) Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
Features co-author Alice Maupin, MSN, RN

ER-Positive/ HER2-Negative Breast Cancer condition guide (The Mighty)
Features Rani Bansal, MD

The many aspects of early detection and interception of cancer (AACR Blog)
Features Shelley Hwang, MD, MHS

Vorasidenib alone improved progression-free survival in patients with residual or recurrent IDH-mutant low-grade glioma, meeting the primary end point of the phase 3 INDIGO trial (Targeted Oncology)
Features Katy Peters, MD, PhD

Opening Plenary Session showcases important breakthroughs across the spectrum of cancer research (AACR)
Features Tomi Akinyemiju, PhD

Creating a ‘parts list’ for cancer’s spread, with help from a worm (Oncology News)
Features David Sherwood, PhD

Adjuvant Endocrine Therapy for Localized Breast Cancer – Key Facts for Primary Care Providers (CME-certified (0.5 credit) tweetorial)
Features Rani Bansal, MD

Response to Bipolar Androgen Therapy and PD-1 Inhibition in a Patient with Metastatic Castration-Resistant Prostate Cancer and a Germline CHEK2 Mutation - Beyond the Abstract (UroToday)
Features Andrew Armstrong, MD, MSc